MedPath

SIBBORAN

SIBBORAN

Approved
DIN Number

02543338

Drug Class

Human

Market Date

Aug 11, 2024

Company
HC

trimedic therapeutics inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02543338
AIG Number0165341001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C07AB14 LANDIOLOL
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification24:24.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

LANDIOLOL HYDROCHLORIDEActive
Strength: 300 MG / VIAL
Monograph: LANDIOLOL HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.